Sign in Subscribe

screening-procedure

A collection of 109 issues

Symptom Identification Critical for Adults 18-44

Skip to content The CRC Digest Symptom Identification Critical for Adults 18-44 Adults under 45 without access to average-risk screening require a well-defined system for symptom identification and workup to avoid diagnostic delays and worse outcomes. (Cancer Epidemiology, Biomarkers & Prevention) This content is informational only and does not constitute

FIT Remains Cornerstone of Population-Based CRC Screening

Skip to content The CRC Digest ▪ SCREENING FIT Remains Cornerstone of Population-Based CRC Screening Fecal immunochemical testing (FIT) continues to be the foundation of organized colorectal cancer screening programs due to its noninvasive nature, affordability, and proven mortality reduction, though stool DNA tests may serve as complementary options in hybrid

Study Examines Symptoms as Diagnostic Indicators in Adults Under 45

Skip to content The CRC Digest ▪ SCREENING Study Examines Symptoms as Diagnostic Indicators in Adults Under 45 (Cancer Epidemiology, Biomarkers & Prevention) This content is informational only and does not constitute medical advice. Always consult your oncologist or care team. © 2026 The CRC Digest — crcdigest.com

Gut microbiome signatures show promise for non-invasive detection of colorectal neoplasia

Skip to content The CRC Digest ▪ SCREENING Gut microbiome signatures show promise for non-invasive detection of colorectal neoplasia Multinational metagenomic studies have identified reproducible microbial signatures associated with CRC, offering a potential alternative to current stool-based tests that have limited sensitivity for adenoma detection. (Journal of Gastroenterology) This content is

Multi-cancer blood tests may not match colonoscopy for colorectal cancer prevention

Skip to content The CRC Digest ▪ SCREENING Multi-cancer blood tests may not match colonoscopy for colorectal cancer prevention A modeling study found that multi-cancer early detection blood tests offer little opportunity for cancer prevention through precursor lesion removal, raising questions about whether detecting multiple cancers can offset the loss of

Canadian Symposium Highlights Care Gaps for Early-Onset Cancer Patients

Skip to content The CRC Digest Canadian Symposium Highlights Care Gaps for Early-Onset Cancer Patients The 2025 Early Age Onset Cancer Symposium identified critical gaps including diagnostic delays, screening eligibility criteria that no longer reflect current disease epidemiology, and insufficient age-appropriate infrastructure for patients under 50. (Curr Oncol) This content

FIT Performance Data Now Available for Adults 55 and Younger

Skip to content The CRC Digest ▪ SCREENING FIT Performance Data Now Available for Adults 55 and Younger A cross-sectional German study of 1,724 participants aged 55 or younger assessed fecal immunochemical test (FIT) diagnostic performance at various fecal hemoglobin cutoffs for detecting advanced neoplasia, addressing a critical data gap

Six-Marker Blood Test Shows Promise for CRC Screening in High-Risk Patients

Skip to content The CRC Digest ▪ SCREENING Six-Marker Blood Test Shows Promise for CRC Screening in High-Risk Patients A prospective study evaluated a multi-target DNA methylation panel (Septin9 region 1, BCAT1, IKZF1, BCAN, VAV3, Septin9 region 2) assessed in plasma samples for colorectal cancer risk stratification, offering a potential non-invasive

Study Assesses New FIT Buffer for Hemoglobin Preservation

Skip to content The CRC Digest ▪ SCREENING Study Assesses New FIT Buffer for Hemoglobin Preservation A study assessed the faecal hemoglobin preservation capacity of a new faecal immunochemical test buffer formulation (SOC4) at varying temperatures and storage times. Fresh faecal samples were collected using buffers containing either the standard (SOC3)

Childhood Cancer Survivors Underutilize Colorectal Cancer Screening

Skip to content The CRC Digest ▪ SCREENING Childhood Cancer Survivors Underutilize Colorectal Cancer Screening A French national study found that childhood cancer survivors participated in fecal immunochemical testing at rates of 20.0% to 23.2% across three screening periods—significantly lower than the general population—despite their elevated CRC